BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 13, 2026
Home » Topics » Analysis and data insight, Medical technology

Analysis and data insight, Medical technology
Analysis and data insight, Medical technology RSS Feed RSS

Med-tech gainers and losers for Jan. 8-12, 2024

Jan. 16, 2024
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Jan. 1-5, 2024

Jan. 8, 2024
The top 10 med-tech stock gainers and losers for the week.
Read More
Med-tech financings December 2023

$1B raised in December, but 2023 med-tech financings down 54%

Jan. 5, 2024
By Amanda Lanier
Med-tech financings exceeded $1 billion for the third consecutive month, reaching a total of $1.07 billion in transactions in December. In November, med-techs raised $1.02 billion, with $1.23 billion raised in October. The overall average for financings in 2023 stands at $1.47 billion per month, down from a monthly average of $3.19 billion the previous year.
Read More

Med-tech gainers and losers for Dec. 26-29, 2023

Jan. 2, 2024
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Dec. 18-22, 2023

Dec. 27, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Dec. 11-15, 2023

Dec. 18, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
medtech deals
Med-tech deals November 2023

November sees $441M in deals, cumulative value up 34% YOY

Dec. 15, 2023
By Amanda Lanier

Total med-tech deal value through November is up 34.42% over the same period last year and is also higher than every comparable period from 2019-2022. Conversely, med-tech M&A value experienced a decline of 64.07% compared to the first 11 months of 2022.


Read More
Dollar symbol with arrow graph

Med-tech gainers and losers for Dec. 4-8, 2023

Dec. 11, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
Stock chart, red down arrow
Med-tech financings November 2023

Med-tech financings mark YOY decline, November sees more than $1B raised

Dec. 8, 2023
By Amanda Lanier
Med-tech financings surpassed $1 billion again in November, with transactions totalling $1.02 billion for the month. Though a decline from the $1.23 billion raised in October, the value is up from September’s $645.75 million.
Read More

Med-tech gainers and losers for Nov. 27-Dec. 1, 2023

Dec. 4, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
Previous 1 2 … 18 19 20 21 22 23 24 25 26 … 54 55 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent

    BioWorld Science
    Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing